Skip to main content
Category

News Archive

ourcrowd-logo

Equity crowdfunding platform OurCrowd launches $50M digital health fund – MobiHealthNews

By News Archive

ourcrowd-logo

Israeli equity crowdfunding platform OurCrowd has launched a new fund specifically focused on the digital health field, called OurCrowd Qure. They will work with Johns Hopkins University to provide validation of value, market access,  and on-going feedback on the startups.

“I think that crowdfunding for digital health makes a huge amount of sense,” John Medved, CEO of OurCrowd, told MobiHealthNews. “We’re not just raising money in a different way. We’re helping to build the company in a different way. A crowdfunding platform is uniquely positioned to help digital health leaders.”

Read More

CSSi LifeSciences™ Launches Fully Integrated Medical Device CRO

By News Archive

	
CSSi-LifeSciences-logo

CSSi LifeSciences™, a trusted partner from discovery to commercialization for drugs and medical devices, is excited to announce the establishment and launch of its fully integrated Medical Device CRO. CSSi LifeSciences™ Medical Device CRO aims to positively impact the timeline of regulatory clearance and increase profitability for medical device companies, in order to successfully launch its innovative research discoveries and product concepts into the market.

Read More
inova-health-system-logo

Behind Inova’s $100 million venture fund plan to invest in the region’s biotech startups – Washington Business Journal

By News Archive

inova-health-system-logo

Back in February, Inova Health System announced it would create a $100 million venture fund. It offered few details at the time.

But as Inova officials celebrated another milestone Wednesday with an new University of Virginia partnership on multiple medical, research and business fronts, CEO Knox Singleton finally offered some details on Inova’s investment plans.

Read More

Actelion obtains an option to in-license vamorolone from ReveraGen

By News Archive

Vamorolone, a novel compound for the treatment of Duchenne Muscular Dystrophy, holds potential to better preserve muscle function and prolong ambulation for the patient, without some of the side effects associated with glucocorticoid therapy.  

ALLSCHWIL, SWITZERLAND, and ROCKVILLE (MD), USA – 03 November 2016 – Actelion Ltd (SIX: ATLN) and ReveraGen BioPharma, Inc., a privately held company engaged in the discovery and development of proprietary therapeutic products for neuromuscular and inflammatory diseases, announced today that they have entered into an agreement. By this agreement, Actelion has obtained an exclusive option to in-license ReveraGen’s lead compound vamorolone for the treatment of Duchenne Muscular Dystrophy at two different stages in its development.

Read More

Sign up Today and Spread the Word: 2016 International Trade Forum-DEC 9

By News Archive

Montgomery Community Media in partnership with the Maryland/DC District Export Council, the US Commercial Service, the Maryland Department of Commerce, and the Small Business Administration present a three-hour program on the challenges and opportunities facing companies going global.
The program will feature 3 panels covering key aspects of international trade, including trade finance and local resources that facilitate trade. Speakers include government executives as well as CEOs who have successfully taken their companies international.

The program will be filmed in front of a studio audience of business leaders and will be streamed live to http://www.MCMLive.org.

Follow this link to learn more about the previous forum and to watch the panels online: http://www.mymcmedia.org/forum-on-international-trade/

Register

big idea connectpreneur logo

CONNECTpreneur Super Early Bird expiring, join us now!

By News Archive

big-idea-connectpreneur-logo

Wednesday, December 14, 7 – 11 amFalls Church Marriott Fairview Park

Super Early Bird expires November 3rd for our CONNECTpreneur Winter Forum, headlined by Revolution Chairman & CEO, STEVE CASE, former AOL Time Warner Chair and New York Times bestselling author of The Third Wave.

The Big Idea CONNECTpreneur FORUM has been called “The Best Networking Event in DC.” DCInno calls CONNECTpreneur a “NETWORKING JACKPOT” of the DC Region’s TOP Entrepreneurs, Business Leaders, CXOs, Angels, and VCs.

Read More
sbir sttr seed fund logo

Give NIH Your Feedback on Improving Diversity in its SBIR/STTR Programs – NIH Extramural Nexus

By News Archive

sbir-sttr-seed-fund-logo

NIH is committed to improving the participation of all people in our small business research SBIR & STTR programs. One of the goals of the SBIR and STTR programs is to encourage participation in innovation and entrepreneurship by socially and economically disadvantaged small businesses (SDB) and women-owned small businesses (WOSB), groups who historically have been underrepresented in both the SBIR/STTR applicant and awardee pools, and have slightly lower success rates than applicants across the board.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.